LIFE Nutrition founded

New manufacturing plant of Braun Meslungen AG

B. Braun Melsungen AG laid the foundation stone for a new manufacturing plant for production and development in nutrition solutions. The new production site includes a research lab and costs around 190 million Euro. In the future 270 employees will work on innovative denouements for the world market.

Webcam Picture of the LIFE Nutrition works Pfieffewiesen
Webcam Picture of the LIFE Nutrition works Pfieffewiesen
During the official ceremony Chairman Prof. Dr. h. c. Ludwig Georg Braun emphasised the significance of this investment for the whole company. “LIFE nutrition will further strengthen our position as a provider of innovative nutrition solutions. The major investment in Germany play a part in contributing to satisfy the requirements of a fast changing world market.”
 
The LIFE Nutrition manufacturing plant in Melsungen ist part of a large-scale project in order to expedite the development and production of nutrition solutions. The results of 8 sub-projects flow together here including the sections pharmaceutical development, sterilisation, bag productio and development of package. “Of particular importance is the collateral workflow of the projects so that the results can effect the others and let the whole be a success,” says Dr. Meinrad Lugan, member of the board and responsible for the Hospital Care section. “That’s a total new thing at B.Braun.”
 
Two lines of bag production will grow out of LIFE Nutrition: The bags are used for clinical nutrition and are filled up with amino acid solutions, carbohydrate solutions or fat emulsions. Therefore three types of bags are applied. For one thing bags with two or three cabins which are conjoined with thin stitches are produced. When you press the bag the fluids diffuse. For another thing so called mono bags can be used for the nutrients. These settlers with only one cabin are of different size.
 
LIFE Nutrition is part of an international investment program in the amount of 1,4 mrd. Euro worldwide. By half of the fund allocates into investment projects at the company’s German locations, about 360 mio. Euro into new and extending buildings in Melsungen.
 

12.08.2008

Read all latest stories

Related articles

Photo

Food supplementation

Can 'fortified' flour fight vitamin D deficiency?

Adding vitamin D to wheat flour would prevent 10 million new cases of vitamin D deficiency in England and Wales over the next 90 years, say researchers at the University of Birmingham. The…

Photo

Small pill, great impact

Antibiotic resistance can be caused by small amounts of antibiotics

Antibiotic-resistant bacteria are a global and growing problem in health care. To be able to prevent further development of resistance developing, it is important to understand where and how…

The UK pharma industry

In the lead up to further talks on medicine pricing, Stephen Whitehead, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI) has accused the UK government of being too…

Related products

Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH